Cefpodoxime-induced hyperprolactinemic galactorrhea.
Khurana
Vishal
V
Gambhir
Indrajeet Singh
IS
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D015296:Ceftizoxime / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D000097623:Cefpodoxime
D000900:Anti-Bacterial Agents; D015296:Ceftizoxime; D000097623:Cefpodoxime